QQ客服 官方微博 反馈留言

	Gold nanocages with dual modality for image-guided therapeutics
	Bao, Shijin[1]; Huang, Shengnan[2]; Liu, Ying[3]; Hu, Yurong[4]; Wang, Weiping[5]; Ji, Mengfei[6]; Li, Huili[7]; Zhang, Ning Xia[8]; Song, Chengzhi[9]; Duan, Shaofeng[10]
刊名	NANOSCALE
	2017
卷号	9期号:21页码:7284-7296
ISSN号	2040-3364
DOI	http://dx.doi.org/10.1039/c7nr01350g
URL标识	查看原文
收录类别	SCI(E) ; EI
WOS记录号	WOS:000402600500040
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5187851
专题	河南大学
作者单位	1.[1]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 2.[2]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 3.[3]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 4.[4]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 5.Zhengzhou Univ, Inst Drug Discovery & Dev, Key Lab Key Technol Drug Preparat, Minist Educ, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 6.[5]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 7.[6]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 8.[7]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 9.[8]Key Lab Targeting Therapy & Diag Crit Dis, Zhengzhou 450001, Henan Province, Peoples R China.,Collaborat Innovat Ctr New Drug Res & Safety Eval, Zhengzhou 450001, Henan Province, Peoples R China.,Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Peoples R China. 10.[9]Zhengzhou Foreign Language Sch, Fengyang St, Zhengzhou 450001, Peoples R China.
推荐引用方式 GB/T 7714	Bao, Shijin[1],Huang, Shengnan[2],Liu, Ying[3],et al. Gold nanocages with dual modality for image-guided therapeutics[J]. NANOSCALE,2017,9(21):7284-7296.
APA	Bao, Shijin[1].,Huang, Shengnan[2].,Liu, Ying[3].,Hu, Yurong[4].,Wang, Weiping[5].,...&Duan, Shaofeng[10].(2017).Gold nanocages with dual modality for image-guided therapeutics.NANOSCALE,9(21),7284-7296.
MLA	Bao, Shijin[1],et al."Gold nanocages with dual modality for image-guided therapeutics".NANOSCALE 9.21(2017):7284-7296.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。